These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23623661)

  • 1. Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.
    Lu M; Breyssens H; Salter V; Zhong S; Hu Y; Baer C; Ratnayaka I; Sullivan A; Brown NR; Endicott J; Knapp S; Kessler BM; Middleton MR; Siebold C; Jones EY; Sviderskaya EV; Cebon J; John T; Caballero OL; Goding CR; Lu X
    Cancer Cell; 2013 May; 23(5):618-33. PubMed ID: 23623661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth.
    Pandolfi S; Montagnani V; Lapucci A; Stecca B
    Cell Death Differ; 2015 Dec; 22(12):2006-19. PubMed ID: 26024388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63-dependent manner.
    Zou H; Zou R; Chen K; Zhu C; Tian X; You Y; He X
    J Cell Biochem; 2018 Nov; 119(11):9217-9228. PubMed ID: 30105797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting p53 in melanoma.
    Box NF; Vukmer TO; Terzian T
    Pigment Cell Melanoma Res; 2014 Jan; 27(1):8-10. PubMed ID: 24118922
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclin B1/Cdk1 phosphorylation of mitochondrial p53 induces anti-apoptotic response.
    Nantajit D; Fan M; Duru N; Wen Y; Reed JC; Li JJ
    PLoS One; 2010 Aug; 5(8):e12341. PubMed ID: 20808790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDK9 inhibitors reactivate p53 by downregulating iASPP.
    Wu J; Liang Y; Tan Y; Tang Y; Song H; Wang Z; Li Y; Lu M
    Cell Signal; 2020 Mar; 67():109508. PubMed ID: 31866490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex.
    de Polo A; Luo Z; Gerarduzzi C; Chen X; Little JB; Yuan ZM
    J Mol Cell Biol; 2017 Apr; 9(2):154-165. PubMed ID: 27927748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.
    Liu Q; Mier JW; Panka DJ
    Mol Cancer; 2011 Sep; 10():115. PubMed ID: 21929745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.
    Woodard C; Liao G; Goodwin CR; Hu J; Xie Z; Dos Reis TF; Newman R; Rho H; Qian J; Zhu H; Hayward SD
    J Virol; 2015 Sep; 89(18):9232-41. PubMed ID: 26109723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F1-dependent oncogenic addiction of melanoma cells to MDM2.
    Verhaegen M; Checinska A; Riblett MB; Wang S; Soengas MS
    Oncogene; 2012 Feb; 31(7):828-41. PubMed ID: 21743494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells.
    Qiu S; Liu S; Yu T; Yu J; Wang M; Rao Q; Xing H; Tang K; Mi Y; Wang J
    BMC Cancer; 2017 Nov; 17(1):795. PubMed ID: 29179704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-anilino-4-amino-5-aroylthiazole-type compound AS7128 inhibits lung cancer growth through decreased iASPP and p53 interaction.
    Cheng HW; Chein RJ; Cheng TJ; Wu PS; Wu HY; Hung PF; Wang CJ; Hsu YL; Wong JM; Yuan A; Wong CH; Yang PC; Pan SH
    Cancer Sci; 2018 Mar; 109(3):832-842. PubMed ID: 29285847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin B1 interacts with the BH3-only protein Bim and mediates its phosphorylation by Cdk1 during mitosis.
    Mac Fhearraigh S; Mc Gee MM
    Cell Cycle; 2011 Nov; 10(22):3886-96. PubMed ID: 22071694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Antiproliferative Activity of Oxypeucedanin via Induction of G
    Park SH; Hong JY; Park HJ; Lee SK
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31979361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E/K)BRAF melanoma to vemurafenib.
    Krayem M; Journe F; Wiedig M; Morandini R; Najem A; Salès F; van Kempen LC; Sibille C; Awada A; Marine JC; Ghanem G
    Eur J Cancer; 2016 Mar; 55():98-110. PubMed ID: 26790143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vemurafenib synergizes with nutlin-3 to deplete survivin and suppresses melanoma viability and tumor growth.
    Ji Z; Kumar R; Taylor M; Rajadurai A; Marzuka-Alcalá A; Chen YE; Njauw CN; Flaherty K; Jönsson G; Tsao H
    Clin Cancer Res; 2013 Aug; 19(16):4383-91. PubMed ID: 23812671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53.
    Canner JA; Sobo M; Ball S; Hutzen B; DeAngelis S; Willis W; Studebaker AW; Ding K; Wang S; Yang D; Lin J
    Br J Cancer; 2009 Sep; 101(5):774-81. PubMed ID: 19707204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer.
    Shangary S; Ding K; Qiu S; Nikolovska-Coleska Z; Bauer JA; Liu M; Wang G; Lu Y; McEachern D; Bernard D; Bradford CR; Carey TE; Wang S
    Mol Cancer Ther; 2008 Jun; 7(6):1533-42. PubMed ID: 18566224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase inhibitors sensitize tumor cells to nutlin-induced apoptosis: a potent drug combination.
    Cheok CF; Dey A; Lane DP
    Mol Cancer Res; 2007 Nov; 5(11):1133-45. PubMed ID: 18025259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.